HIVR4P 2016: Second Case Report of PrEP Failure Due to Drug-Resistant Virus
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Tuesday, 18 October 2016 00:00
- Written by Roger Pebody
A PrEP user in New York City has become HIV-positive with virus that is resistant to Truvada and other antiretroviral drugs, according to a report presented Tuesday at the HIV Research for Prevention (HIVR4P 2016) conference in Chicago. This is only the second such case that has been reported, highlighting the rarity -- but not the impossibility -- of HIV infections among people who adhere to their pre-exposure prophylaxis (PrEP) medication schedule.
HIVR4P 2016: Anal Sex May Transmit 4 in 10 HIV Infections Among High-Risk U.S. Women
- Details
- Category: HIV Sexual Transmission
- Published on Tuesday, 18 October 2016 00:00
- Written by Gus Cairns
A study presented at the HIV Research for Prevention conference this week in Chicago suggests that among women at high risk for HIV infection, 40% or more infections might be transmitted via anal intercourse. Because HIV is transmitted, according to different estimates, from 2 to 18 times more easily via anal than vaginal sex (the Centers for Disease Control and Prevention's estimate is 12 times), anal intercourse could be a major -- or even predominant -- contributor to HIV infections in heterosexual women, even if anal sex accounts for only 5%-10% of all sex.
AIDS 2016: How Can Clinical Services Engage Men Who Have Sex With Men in Africa?
- Details
- Category: HIV Prevention
- Published on Tuesday, 20 September 2016 00:00
- Written by Roger Pebody
Men who have sex with men (MSM) living in African countries have an extremely high burden of HIV, Stefan Baral of Johns Hopkins University reminded delegates at the recent 21st International AIDS Conference (AIDS 2016) in Durban. But in situations often marked by widespread social disapproval of homosexual behavior, health services for MSM are few and far between.
Truvada PrEP Linked to Rare Case of Serious Kidney Disorder
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Wednesday, 05 October 2016 00:00
- Written by Liz Highleyman
Researchers in Southern California have identified the first known case of Fanconi syndrome, a type of serious kidney dysfunction, in an otherwise healthy man taking Truvada (tenofovir/emtricitabine) for pre-exposure prophylaxis (PrEP), according to a poster presented at the 18th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV last month in New York City. This case underlines the importance of regular kidney function monitoring while on PrEP.
AIDS 2016: NYC Clinic Outlines How to Improve PrEP Uptake by Transgender People
- Details
- Category: HIV Prevention
- Published on Tuesday, 20 September 2016 00:00
- Written by Roger Pebody
Dedicated efforts are needed to engage transgender men and women with clinical services and to encourage them to use pre-exposure prophylaxis (PrEP), Asa Radix from the Callen-Lorde Community Health Center in New York said during a presentation at the recent 21st International AIDS Conference (AIDS 2016) in Durban.
More Articles...
- Nationwide PrEP Search Engine Debuts at U.S. Conference on AIDS
- AIDS 2016: Vaginal Ring for HIV Prevention is Effective and Acceptable
- AIDS 2016: PrEP Study Achieves High Engagement and Adherence Among Black Gay Men
- AIDS 2016: Study Looks at Use of HIV PrEP Before and During Pregnancy and Breastfeeding